Larimar Therapeutics Inc (LRMR) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $5.52
• Market Cap: $509.26M
• EPS: $-1.96
• 52-Week High: $6.42
• 52-Week Low: $1.61

Market Sentiment

Larimar Therapeutics Inc currently has a Bullish sentiment score of 0.46.

About Larimar Therapeutics Inc

Larimar Therapeutics, Inc. is a clinical-stage biotechnology company based in Bala Cynwyd, Pennsylvania, focused on developing innovative therapies for rare diseases characterized by significant unmet medical needs. Leveraging advanced technologies and deep scientific expertise, the company is committed to improving patient outcomes through its promising drug pipeline. With strategic partnerships and a clear vision for leadership in the rare disease sector, Larimar is well-positioned to deliv...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Larimar Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does LRMR pay dividends?

Larimar Therapeutics Inc (LRMR) does not currently pay a regular dividend.

What is LRMR's market cap?

Larimar Therapeutics Inc (LRMR) has a market capitalization of $509.26M with a current stock price of $5.52.